Assessment and significance of abdominal aortic calcification in chronic kidney disease

Assessment and significance of abdominal aortic calcification in chronic kidney disease
复制标题

DOI:
10.1093/ndt/gfp728
复制
发表时间:
2010-06-01
影响因子:
6.1
通讯作者:
Sasaki, Sei
Sasaki, Sei
中科院分区:
医学1区
文献类型:
--
作者:
Hanada, Shigeru;Ando, Ryoichi;Sasaki, Sei

文献摘要

被引文献

相似文献

背景。腹主动脉钙化是透析患者常见的并发症,也是心血管疾病死亡率的预测因子。然而,腹主动脉钙化在透析前慢性肾脏疾病(CKD)中的作用尚不清楚。对101名日本成人透析前CKD患者(平均年龄66.6 +/- 11.3岁)(分别为3,4和5期18,29和54)进行了队列研究。入路时,采用非对比计算机断层扫描确定腹主动脉钙化指数(Ad)。临床特征和实验室变量也进行了评估。随访时间平均为48个月。其中82%的受试者存在腹主动脉钙化(CKD 3期、4期和5期分别为50%、83%和91%),中位ACI为16.7%(分别为8.5%、20.0和21.4%)。多因素logistic回归分析发现,年龄、糖尿病的存在和肾小球滤过率(e-GFR)的降低是主动脉钙化存在(ACI> = 0%)和程度(ACI> = 20%)的独立预测因素。多因素Cox比例风险分析发现ACT 20%和糖尿病是CKD 4期和5期新发心血管事件的独立预测因素。GFR降低可能与腹主动脉钙化的存在和程度有关,高水平的钙化可能与透析前CKD的新生心血管事件有关,表明阐明CKD促进血管钙化的机制可能会改善透析前CKD患者的预后。
Background. Abdominal aortic calcification is a common complication and a predictor of cardiovascular mortality in dialysis patients. However, abdominal aortic calcification in pre-dialysis chronic kidney disease (CKD) is poorly understood.Methods. A cohort study of 101 adult Japanese patients (mean age 66.6 +/- 11.3 years old) with pre-dialysis CKD (18, 29 and 54 in stages 3, 4 and 5, respectively) was performed. At entry, a non-contrast computed tomography scan was used to determine the abdominal aortic calcification index (Ad). Clinical characteristics and laboratory variables were also assessed. The patients were followed for a mean period of 48 12 months.Results. Among the subjects, 82% had abdominal aortic calcification (50, 83 and 91% for CKD stages 3, 4 and 5, respectively), and the median ACI was 16.7% (8.5, 20.0 and 21.4%, respectively). Multivariate logistic regression analyses identified older age, presence of diabetes and decreased estimated glomerular filtration rate (e-GFR) as independent predictors of the presence (ACI>0%) and extent (ACI >= 20%) of aortic calcification. Multivariate Cox proportional hazards analysis identified ACT 20% and diabetes as independent predictors for de novo cardiovascular events in CKD stages 4 and 5.Conclusion. Decreased GFR may be associated with the presence and extent of abdominal aortic calcification, and a high level of calcification may be associated with de novo cardiovascular events in pre-dialysis CKD, suggesting that elucidation of the mechanism through which CKD contributes to vascular calcification may lead to an improved prognosis in patients with pre-dialysis CKD.